Open the map

Zimmer BiometZBH

Medtech & devices · NYSE · USA

$88.88
Up 0.4% todayClose

Down 1.6% this year and −4.5% since June 26, behind the life science sector at +10.7%. Zimmer Biomet supplies 1 mapped company.

This year
−1.6%
1 year
−10.7%
P/E
21.5
P/S
2.0
P/B
1.4

Price vs the life science sector

since Jun 26ZBHLife science sector, equal weight
Zimmer Biomet (ZBH) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ZBH: −4.5% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8ZBH −4.5%Sector +10.7% Zimmer Biomet (ZBH) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ZBH: −4.5% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8ZBH−4.5%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedCardinal Health (CAH)CAHCardinal Health+2.9%ZBHZimmer Biomet Open the full chain →

About Zimmer Biomet

Artificial knees and hips, trauma implants, surgical robotics.

Theme exposure

Orthopedic implantsOrthopedicsImplantsRobotic surgery

Products

  • Knee & hip implants
  • Trauma & extremity products
  • Surgical robotics

Competitors

  • Stryker
  • DePuy Synthes (J&J)
  • Smith+Nephew

Risks

  • Implant pricing pressure
  • Robotic surgery competition

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Compare ZBH

Side by side with the largest companies in the same segment.

See where Zimmer Biomet sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →